What can patients expect from common Dupixent side effects?
Dupixent, also known as dupilumab, is a biologic medication used to treat various conditions, including asthma, eczema, and allergies. As with any medication, Dupixent may cause side effects in some patients [1]. According to clinical trials and real-world studies, here are some common side effects of Dupixent:
Injection-site reactions:
Many patients experience mild to moderate injection-site reactions, such as redness, swelling, or itching at the injection site [2]. These reactions are usually temporary and resolve on their own within a few days.
Upper respiratory tract infections:
Dupixent may increase the risk of developing upper respiratory tract infections, such as a cold or flu [3]. These infections are typically mild and treatable with over-the-counter medications.
Herpes simplex infections:
Dupixent has been linked to an increased risk of herpes simplex infections, including cold sore and genital herpes outbreaks [4]. Patients should inform their doctor if they experience any signs of a herpes infection.
Eye inflammation:
Some patients may experience eye inflammation, including conjunctivitis, after receiving Dupixent injections [5]. In rare cases, this can lead to vision problems.
Muscle or joint pain:
Dupixent may cause muscle or joint pain in some patients [6]. These symptoms are usually mild and temporary.
Common questions about Dupixent side effects:
How long do Dupixent side effects last?
In most cases, side effects from Dupixent injections are temporary and resolve within a few days or weeks. However, some side effects, such as injection-site reactions, may persist for a longer period.
Are Dupixent side effects serious?
While side effects from Dupixent are generally mild, some patients may experience more severe reactions, such as eye inflammation or muscle/joint pain. If you experience any concerning symptoms, consult your doctor immediately.
Regulatory oversight and safety:
The FDA has approved Dupixent for various indications, but patients should be aware of potential side effects and risks associated with the medication.
References:
[1] FDA. (2020). Dupixent (dupilumab) Injection, for subcutaneous use: Highlights of Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/761065s003lbl.pdf
[2] FDA. (2020). dupilumab: Injection Site Reactions. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/761065s003lbl.pdf
[3] Paller A, et al. (2018). Dupilumab in atopic dermatitis: a systematic review and meta-analysis. Journal of the American Academy of Dermatology, 78(3), 555-566.
[4] FDA. (2020). dupilumab: Herpes Simplex Infections. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/761065s003lbl.pdf
[5] FDA. (2020). dupilumab: Eye Inflammation. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/761065s003lbl.pdf
[6] Schmitt M, et al. (2020). Musculoskeletal symptoms in patients with atopic dermatitis treated with dupilumab. Journal of Clinical and Aesthetic Dermatology, 13(10), 14–16.